0102030405
Voxilaprevir Intermediates CAS NO 1360828-80-3 Pharmaceutical Intermediates
02
introduce
VOXILAPREVIR INT is a pharmaceutical compound specifically designed to treat hepatitis C virus (HCV) infection. As a manufacturing and trading facility, we ensure that our products meet the highest quality and efficacy standards. Voxilaprevir is a potent and selective inhibitor of NS3/4A protease, an enzyme essential for the replication of the hepatitis C virus. The compound is designed to provide targeted therapy to improve patient outcomes in HCV management.
02
Physical and chemical properties
The compound possesses a range of physical and chemical properties that enhance its suitability for pharmaceutical applications:
- Molecular formula: C9H15ClF2N2O3S
- Molecular weight: 304.74 g/mol
- Appearance: White to Off-White solid
- Solubility: Soluble in organic solvents such as DMSO and methanol; limited solubility in water
- Stability: Stable under standard storage conditions; should be protected from light and moisture to maintain its integrity.
- Melting point: approx. 150-155°C
The unique structure of voxilaprevir enables it to interact specifically with the NS3/4A protease, effectively inhibiting viral replication. This targeted action is critical for the successful treatment of HCV infection.
1. Targeted Action: Worxiprevir specifically targets the NS3/4A protease, providing a targeted treatment approach for HCV patients, leading to better treatment responses and outcomes.
2. Enhanced efficacy: The innovative mechanism of action can effectively inhibit HCV replication, which is crucial for patients to achieve sustained virological response (SVR).
3. Versatile: This compound can be used in a variety of pharmaceutical formulations, including oral tablets and combination therapies, making it a versatile option for healthcare providers.
4. Research and Development: Worxiprevir is well suited for use in clinical settings and may facilitate the development of new treatment options and strategies for managing HCV, particularly for patients with drug-resistant strains.
5. Regulatory Compliance: Our products adhere to all relevant regulatory standards, ensuring they are safe and effective in pharmaceutical applications.
VOXILAPREVIR INT is a premium compound that stands out in the pharmaceutical industry for its unique properties and benefits. Its high purity, targeted action and enhanced efficacy make it an essential ingredient for pharmaceutical companies and healthcare providers seeking to innovate and improve treatment options for hepatitis C patients.
Our commitment to quality and regulatory compliance ensures you receive products that meet the highest standards. Partner with us for your pharmaceutical needs and experience the benefits of our advanced chemistry solutions. For more information or to place an order, contact us today!
By choosing VOXILAPREVIR INT, you invest in a product that not only meets but exceeds the expectations of the pharmaceutical industry, paving the way for innovative therapeutic solutions. Our extensive experience in manufacturing and trading ensures that you receive a reliable and effective product tailored to your specific needs.